Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy

J Oral Pathol Med. 2008 Oct;37(9):555-9. doi: 10.1111/j.1600-0714.2008.00670.x. Epub 2008 Mar 19.

Abstract

Background: To evaluate the prevalence of human papilloma virus (HPV) infection and types in the oral and cervix mucosa of treatment-naïve HIV-1-positive women with CD4 counts less than 300 cells per ml with no HPV-associated oral lesions.

Methods: Oral epithelium was harvested from the buccal mucosa and lateral borders of the tongue and cervical samples were collected from the endocervical area of 30 women, 22-64 years old. Cytobrush Plus cell collectors were used for sampling both anatomical areas. Genital pathology, obstetric and gynaecological history, co-morbid disease, hormone therapy, sexual behavior and smoking history were assessed via physical examination and clinical interviews. Special investigations included cervical Papanicolau smears, CD4 counts and HIV-1 viral loads. The linear array HPV test was used to determine HPV genotypes present in the specimens.

Results: Oral HPV were identified in 20% (n = 6) of the patients, of which two had infection with two HPV types. Genital HPV was found in 96.7% (n = 29) of the women, of which only 14 had cytological abnormalities on Papanicolau smear. Infection with multiple HPV types were present in 93.1% (n = 27) of the patients, with an average of four HPV types per individual.

Conclusions: South African HIV-positive women with CD4 counts less than 300 cells per ml have a significant risk of cervical HPV strains and multiple strain infection of the cervix. The prevalence of HPV in normal oral mucosa was low but high-risk types were present. Limited correlation between oral HPV types and those identified in the cervical mucosa was found.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / immunology
  • AIDS-Related Opportunistic Infections / virology
  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Cervix Uteri / virology
  • DNA, Viral / analysis
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HIV Seropositivity / complications*
  • HIV Seropositivity / immunology
  • HIV Seropositivity / virology
  • HIV-1 / immunology*
  • Humans
  • Middle Aged
  • Mouth Mucosa / virology
  • Mucous Membrane / virology*
  • Papillomaviridae / classification*
  • Papillomaviridae / genetics
  • Papillomavirus Infections / chemically induced
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / virology*
  • Prevalence
  • Risk Factors
  • South Africa
  • Young Adult

Substances

  • Anti-Retroviral Agents
  • DNA, Viral